GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Concord Medical Services Holdings Ltd (NYSE:CCM) » Definitions » Equity-to-Asset

Concord Medical Services Holdings (Concord Medical Services Holdings) Equity-to-Asset : -0.35 (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Concord Medical Services Holdings Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Concord Medical Services Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $-297.18 Mil. Concord Medical Services Holdings's Total Assets for the quarter that ended in Dec. 2023 was $847.87 Mil. Therefore, Concord Medical Services Holdings's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was -0.35.

The historical rank and industry rank for Concord Medical Services Holdings's Equity-to-Asset or its related term are showing as below:

CCM' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.35   Med: 0.03   Max: 0.61
Current: -0.35

During the past 13 years, the highest Equity to Asset Ratio of Concord Medical Services Holdings was 0.61. The lowest was -0.35. And the median was 0.03.

CCM's Equity-to-Asset is ranked worse than
92.75% of 676 companies
in the Healthcare Providers & Services industry
Industry Median: 0.46 vs CCM: -0.35

Concord Medical Services Holdings Equity-to-Asset Historical Data

The historical data trend for Concord Medical Services Holdings's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Medical Services Holdings Equity-to-Asset Chart

Concord Medical Services Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.03 -0.12 -0.22 -0.31 -0.35

Concord Medical Services Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.22 -0.24 -0.31 -0.31 -0.35

Competitive Comparison of Concord Medical Services Holdings's Equity-to-Asset

For the Medical Care Facilities subindustry, Concord Medical Services Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Concord Medical Services Holdings's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Concord Medical Services Holdings's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Concord Medical Services Holdings's Equity-to-Asset falls into.



Concord Medical Services Holdings Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Concord Medical Services Holdings's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=-297.183/847.867
=-0.35

Concord Medical Services Holdings's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=-297.183/847.867
=-0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Concord Medical Services Holdings  (NYSE:CCM) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Concord Medical Services Holdings Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Concord Medical Services Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Concord Medical Services Holdings (Concord Medical Services Holdings) Business Description

Traded in Other Exchanges
N/A
Address
Room 2701-05 , 36 North Third Ring Road, Tower A, Global Trade Center, Dongcheng District, Beijing, CHN, 100013
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers and diagnostic imaging centers and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.